Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Impact of Fluid Choice in Systemic Inflammatory Response Syndrome Patients on Hospital Cost Savings.

Laplante S, Makhija DU, Munson SH, Khangulov VS, Peyerl FW, Paluszkiewicz SM, Ravindranath AJ, Schermer CR.

Pharmacoecon Open. 2018 Sep;2(3):325-335. doi: 10.1007/s41669-017-0055-y.

2.

Cost Savings from Reduced Hospitalizations with Use of Home Noninvasive Ventilation for COPD.

Coughlin S, Peyerl FW, Munson SH, Ravindranath AJ, Lee-Chiong TL.

Value Health. 2017 Mar;20(3):379-387. doi: 10.1016/j.jval.2016.09.2401. Epub 2016 Nov 11.

3.

The role of noninvasive ventilation in the management and mitigation of exacerbations and hospital admissions/readmissions for the patient with moderate to severe COPD (multimedia activity).

White DP, Criner GJ, Dreher M, Hart N, Peyerl FW, Wolfe LF, Chin SA.

Chest. 2015 Jun;147(6):1704-1705. doi: 10.1378/chest.15-0394.

PMID:
26033131
4.

Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS.

Shaw AD, Raghunathan K, Peyerl FW, Munson SH, Paluszkiewicz SM, Schermer CR.

Intensive Care Med. 2014 Dec;40(12):1897-905. doi: 10.1007/s00134-014-3505-3. Epub 2014 Oct 8.

5.

Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.

Joy MS, Karagiannis PC, Peyerl FW.

J Manag Care Pharm. 2007 Jun;13(5):397-411. Review.

6.

Contribution of T-cell receptor repertoire breadth to the dominance of epitope-specific CD8+ T-lymphocyte responses.

Manuel ER, Charini WA, Sen P, Peyerl FW, Kuroda MJ, Schmitz JE, Autissier P, Sheeter DA, Torbett BE, Letvin NL.

J Virol. 2006 Dec;80(24):12032-40. Epub 2006 Oct 11.

7.

Elucidation of some Bax conformational changes through crystallization of an antibody-peptide complex.

Peyerl FW, Dai S, Murphy GA, Crawford F, White J, Marrack P, Kappler JW.

Cell Death Differ. 2007 Mar;14(3):447-52. Epub 2006 Sep 1.

8.
9.

Bax does not have to adopt its final form to drive T cell death.

Zhu Y, Liu X, Hildeman D, Peyerl FW, White J, Kushnir E, Kappler J, Marrack P.

J Exp Med. 2006 May 15;203(5):1147-52. Epub 2006 May 1.

10.
11.

Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.

Sumida SM, Truitt DM, Lemckert AA, Vogels R, Custers JH, Addo MM, Lockman S, Peter T, Peyerl FW, Kishko MG, Jackson SS, Gorgone DA, Lifton MA, Essex M, Walker BD, Goudsmit J, Havenga MJ, Barouch DH.

J Immunol. 2005 Jun 1;174(11):7179-85.

12.

Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.

Barouch DH, Powers J, Truitt DM, Kishko MG, Arthur JC, Peyerl FW, Kuroda MJ, Gorgone DA, Lifton MA, Lord CI, Hirsch VM, Montefiori DC, Carville A, Mansfield KG, Kunstman KJ, Wolinsky SM, Letvin NL.

Nat Immunol. 2005 Mar;6(3):247-52. Epub 2005 Jan 30.

PMID:
15685174
13.

Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope.

Peyerl FW, Bazick HS, Newberg MH, Barouch DH, Sodroski J, Letvin NL.

J Virol. 2004 Dec;78(24):13901-10.

14.

Engineered T-cell receptor tetramers bind MHC-peptide complexes with high affinity.

Subbramanian RA, Moriya C, Martin KL, Peyerl FW, Hasegawa A, Naoi A, Chhay H, Autissier P, Gorgone DA, Lifton MA, Kuus-Reichel K, Schmitz JE, Letvin NL, Kuroda MJ.

Nat Biotechnol. 2004 Nov;22(11):1429-34. Epub 2004 Oct 24.

PMID:
15502816
15.

Structural constraints on viral escape from HIV- and SIV-specific cytotoxic T-lymphocytes.

Peyerl FW, Barouch DH, Letvin NL.

Viral Immunol. 2004;17(2):144-51. Review.

PMID:
15279695
16.

Subsets of memory cytotoxic T lymphocytes elicited by vaccination influence the efficiency of secondary expansion in vivo.

Seaman MS, Peyerl FW, Jackson SS, Lifton MA, Gorgone DA, Schmitz JE, Letvin NL.

J Virol. 2004 Jan;78(1):206-15.

17.

Simian-human immunodeficiency virus escape from cytotoxic T-lymphocyte recognition at a structurally constrained epitope.

Peyerl FW, Barouch DH, Yeh WW, Bazick HS, Kunstman J, Kunstman KJ, Wolinsky SM, Letvin NL.

J Virol. 2003 Dec;77(23):12572-8.

18.

Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice.

Gao F, Li Y, Decker JM, Peyerl FW, Bibollet-Ruche F, Rodenburg CM, Chen Y, Shaw DR, Allen S, Musonda R, Shaw GM, Zajac AJ, Letvin N, Hahn BH.

AIDS Res Hum Retroviruses. 2003 Sep;19(9):817-23.

PMID:
14585212
19.

Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.

Du Pasquier RA, Kuroda MJ, Schmitz JE, Zheng Y, Martin K, Peyerl FW, Lifton M, Gorgone D, Autissier P, Letvin NL, Koralnik IJ.

J Virol. 2003 Nov;77(22):11918-26.

20.

Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys.

Barouch DH, Kunstman J, Glowczwskie J, Kunstman KJ, Egan MA, Peyerl FW, Santra S, Kuroda MJ, Schmitz JE, Beaudry K, Krivulka GR, Lifton MA, Gorgone DA, Wolinsky SM, Letvin NL.

J Virol. 2003 Jul;77(13):7367-75.

21.

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.

Barouch DH, Kunstman J, Kuroda MJ, Schmitz JE, Santra S, Peyerl FW, Krivulka GR, Beaudry K, Lifton MA, Gorgone DA, Montefiori DC, Lewis MG, Wolinsky SM, Letvin NL.

Nature. 2002 Jan 17;415(6869):335-9.

PMID:
11797012

Supplemental Content

Loading ...
Support Center